Overall benefit-risk assessments Statins consistently demonstrated superior effectiveness over control treatments in lowering the risk of all-cause mortality (OR 0.87, 95% CI 0.820.92) and major coronary events (OR 0.69, 95% CI 0.640.75) across various populations
In contrast, Novo Nordisk boasts a much larger market cap of roughly $219 billion and a lower P/E ratio of 13-14, but its stock has faced headwinds, with some analysts issuing 'Hold' ratings and lower price targets around $56-$59, reflecting concerns about market share and pricing
That said, supplementation isnt one-size-fits-all
Previous research has looked at single substances such as alcohol and cannabis, but a 2026 observational study in the British Medical Journal looked at multiple substances and extended its reach into opioids
In 6 months, I lost 39 pounds